Literature DB >> 29572571

Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.

Tanja Stojkovic1,2, Elka Stefanova3,4, Ivan Soldatovic5,4, Vladana Markovic3,4, Iva Stankovic3, Igor Petrovic3,4, Federica Agosta6, Sebastiano Galantucci6, Massimo Filippi6, Vladimir Kostic3,4.   

Abstract

OBJECTIVE: To determine frequency and type of cognitive disorders in cross-sectional analysis of a Parkinson's disease (PD) cohort, and explore its relations to motor symptoms, modifiable vascular risk factors and white matter lesions (WML) volume.
METHODS: In a group of 133 PD patients, mild cognitive impairment (PD-MCI) and dementia (PDD) were diagnosed according to Movement Disorders Society Task Force criteria (level 2 for PD-MCI). Detailed motor measurements were applied, including rigidity, axial, bradykinesia, tremor and postural instability gait disorders (PIGD) scores. Vascular risk was estimated by the Framingham General Cardiovascular Disease risk scoring algorithm and WML volume was measured for whole brain and frontal lobe.
RESULTS: Sixty-one (46.9%) patients fulfilled criteria for PD-MCI, and 23 (17.7%) for PDD. Non-amnestic multiple domain MCI was most frequent (52% of PD-MCI patients). Motor scores were significantly higher in cognitively impaired patients, but only axial score discriminated between MCI and dementia. High vascular risk was related to impaired cognition, bradykinesia, axial, PIGD and freezing of gait (FOG) score, while whole brain WML volume was associated with PDD, FOG and attention deficits. Furthermore, high vascular risk was identified as a potential predictor of both MCI and dementia in PD. Additionally, age and bradykinesia score were independently associated with PD-MCI and age, axial score and whole brain WML volume with PDD.
CONCLUSION: Cognitive disorders in PD are associated with more severe, predominantly axial motor deficits and increased, but partly modifiable vascular burden, thus opening a possibility for development of preventive strategies in PD.

Entities:  

Keywords:  Cognition; Gait; Parkinson’s disease; Vascular risk

Mesh:

Year:  2018        PMID: 29572571     DOI: 10.1007/s00415-018-8838-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

Review 1.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

2.  Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Martin Arend; Katia Longo; Kai Boetzel; Karla Eggert; Wolfgang H Oertel; Richard Dodel; Paolo Barone
Journal:  Parkinsonism Relat Disord       Date:  2011-02-09       Impact factor: 4.891

3.  Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Authors:  V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-04-14       Impact factor: 4.891

4.  Vascular factors in neurodegenerative diseases: a path towards treatment and prevention.

Authors:  Gustavo C Román; François Boller
Journal:  Funct Neurol       Date:  2014 Apr-Jun

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress.

Authors:  Miia Kivipelto; Alina Solomon; Satu Ahtiluoto; Tiia Ngandu; Jenni Lehtisalo; Riitta Antikainen; Lars Bäckman; Tuomo Hänninen; Antti Jula; Tiina Laatikainen; Jaana Lindström; Francesca Mangialasche; Aulikki Nissinen; Teemu Paajanen; Satu Pajala; Markku Peltonen; Rainer Rauramaa; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Hilkka Soininen
Journal:  Alzheimers Dement       Date:  2013-01-17       Impact factor: 21.566

Review 8.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

9.  Association between cognition and function in patients with Parkinson disease with and without dementia.

Authors:  Emily Rosenthal; Laura Brennan; Sharon Xie; Howard Hurtig; Joshua Milber; Daniel Weintraub; Jason Karlawish; Andrew Siderowf
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 10.  Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.

Authors:  Angie A Kehagia; Roger A Barker; Trevor W Robbins
Journal:  Neurodegener Dis       Date:  2012-10-03       Impact factor: 2.977

View more
  11 in total

1.  Cognitive Performance is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson's Disease.

Authors:  Yi-Lun Ge; Si-Yi Gong; Pu-Zhi Wang; Jia-Hui Yan; Wen Li; Jin-Ru Zhang; Hong Jin; Sheng Zhuang; Lei Hu; Chang-Wei Ding; Ya-Ping Yang; Fen Wang; Dan Li; Jing Chen; Cheng-Jie Mao; Ying-Chun Zhang; Kai Li; Chun-Feng Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-12       Impact factor: 2.989

2.  Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.

Authors:  Xiao-Li Si; Lu-Yan Gu; Zhe Song; Cheng Zhou; Yi Fang; Chong-Yao Jin; Jing-Jing Wu; Ting Gao; Tao Guo; Xiao-Jun Guan; Xiao-Jun Xu; Xin-Zhen Yin; Ya-Ping Yan; Min-Min Zhang; Jia-Li Pu
Journal:  Front Aging Neurosci       Date:  2020-11-05       Impact factor: 5.750

Review 3.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 4.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

5.  Characterizing upper limb function in the context of activities of daily living in CLN3 disease.

Authors:  Hanna Hildenbrand; Jordan Wickstrom; Rebecca Parks; Cris Zampieri; Thuy-Tien Nguyen; Audrey Thurm; Kisha Jenkins; Katharine E Alter; Jesse Matsubara; Dylan Hammond; Ariane Soldatos; Forbes D Porter; An N Dang Do
Journal:  Am J Med Genet A       Date:  2021-02-08       Impact factor: 2.578

6.  Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.

Authors:  Mahsa Dadar; Myrlene Gee; Ashfaq Shuaib; Simon Duchesne; Richard Camicioli
Journal:  Neuroimage Clin       Date:  2020-07-17       Impact factor: 4.881

7.  Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.

Authors:  Ting Wang; Feilan Yuan; Zhenze Chen; Shuzhen Zhu; Zihan Chang; Wanlin Yang; Bin Deng; Rongfang Que; Peihua Cao; Yinxia Chao; Lingling Chan; Ying Pan; Yanping Wang; Linting Xu; Qiurong Lyu; Piu Chan; Midori A Yenari; Eng-King Tan; Qing Wang
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

8.  Progressive brain atrophy and clinical evolution in Parkinson's disease.

Authors:  Massimo Filippi; Elisabetta Sarasso; Noemi Piramide; Tanja Stojkovic; Iva Stankovic; Silvia Basaia; Andrea Fontana; Aleksandra Tomic; Vladana Markovic; Elka Stefanova; Vladimir S Kostic; Federica Agosta
Journal:  Neuroimage Clin       Date:  2020-08-07       Impact factor: 4.881

9.  Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.

Authors:  Alessandra Nicoletti; Antonina Luca; Roberta Baschi; Calogero Edoardo Cicero; Giovanni Mostile; Marco Davì; Giuseppe La Bianca; Vincenzo Restivo; Mario Zappia; Roberto Monastero
Journal:  J Neurol       Date:  2020-08-31       Impact factor: 4.849

Review 10.  Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?

Authors:  Chul-Kyu Kim; Perminder S Sachdev; Nady Braidy
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.